CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
22 hedge funds and large institutions have $1.33M invested in Cyclo Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
22
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$25.1K | |
| 2 | +$761 | |
| 3 | +$178 | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$18 |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8 |
Top Sellers
| 1 | -$29.5K | |
| 2 | -$3.02K | |
| 3 | -$2.73K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$485 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$278 |